KARKINOX Trademark

Trademark Overview

On Friday, September 23, 2022, a trademark application was filed for KARKINOX with the United States Patent and Trademark Office. The USPTO has given the KARKINOX trademark a serial number of 97604786. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 28, 2025. This trademark is owned by KarkinoX Pharma, Inc.. The KARKINOX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of oncology; pharmaceutical research and development
karkinox

General Information

Serial Number97604786
Word MarkKARKINOX
Filing DateFriday, September 23, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, May 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and ServicesMedical and scientific research in the field of oncology; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKarkinoX Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMilpitas, CA 95035
Party NameKarkinoX Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMilpitas, CA 95035

Trademark Events

Event DateEvent Description
Tuesday, July 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, September 27, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 6, 2023ASSIGNED TO EXAMINER
Tuesday, July 11, 2023NON-FINAL ACTION E-MAILED
Tuesday, July 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 19, 2023ASSIGNED TO LIE
Tuesday, December 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Monday, October 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 28, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024SOU EXTENSION 1 GRANTED
Monday, October 28, 2024SOU EXTENSION 1 FILED
Wednesday, May 28, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 28, 2025SOU EXTENSION 2 FILED
Wednesday, May 28, 2025SOU EXTENSION 2 GRANTED

Related Keywords

karkinox research pharmaceutical development oncology field scientific medical